Many ASX share prices are falling today. How do I decide what to buy?

April 2025 has started off roughly. What should we buy?

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ASX share market is going through some rough volatility. The S&P/ASX 200 Index (ASX: XJO) is currently down by 4.2%. What are investors supposed to buy when so many share prices have been hit heavily?

It can be hard to choose, so I'll give some thoughts on which areas could be good investments, in my opinion.

When virtually everything is down, almost every investment looks like an appealing opportunity.

This isn't the first time we've seen heavy declines this decade. The COVID-19 crash in 2020 and the inflation hit of 2022 were also painful. We did see a recovery after that, thankfully. In hindsight, those two years were two of the best times to invest over the past decade.

Having said that, I think there are three types of potential investments on the ASX that could make smart buys after the volatility.

The biggest declines

There have been some very steep falls in the last few days, and the overall decline started in mid-February 2025.

Inevitably, some ASX shares drop further than others at times like this. There's no guarantee those investments will recover, but there's good potential for them to rebound stronger than the overall market when confidence returns. We may need to be patient, though.

Some of the businesses I'd view as ideas to recover include GQG Partners Inc (ASX: GQG), Pinnacle Investment Management Group Ltd (ASX: PNI), Lovisa Holdings Ltd (ASX: LOV), Betashares Nasdaq 100 ETF (ASX: NDQ), Global X Fang+ ETF (ASX: FANG), BHP Group Ltd (ASX: BHP), Rio Tinto Ltd (ASX: RIO), Fortescue Ltd (ASX: FMG), Siteminder Ltd (ASX: SDR), and others like that.

I'd want to choose businesses I think have global earnings potential (not limited to the US) and have suffered a heavy share price decline, making them more attractive.

Potential ASX share beneficiaries

There is no certainty about what businesses will be able to succeed during these times.

However, there are bets by the market that the Reserve Bank of Australia (RBA) may be forced to reduce the official cash rate to counter any negative effects of the trade war.

Some businesses have struggled because of high interest rates in the last few years. I think they could be investment opportunities in the current sell-off and benefit if rates are cut.

I'm particularly thinking of property-related ASX shares such as Centuria Industrial REIT (ASX: CIP), Rural Funds Group (ASX: RFF), Brickworks Ltd (ASX: BKW), Metcash Ltd (ASX: MTS), and Charter Hall Long WALE REIT (ASX: CLW).

Exchange-traded funds

Aside from the ASX-listed exchange-traded funds (ETFs) I've already mentioned, I think there are a number of high-quality funds that have fallen, despite the fact they're full of high-quality, resilient businesses.

I'd consider ideas like the VanEck MSCI International Quality ETF (ASX: QUAL), the Betashares Global Quality Leaders ETF (ASX: QLTY), and the VanEck Morningstar Wide Moat ETF (ASX: MOAT).

By investing in ETFs, we can spread the risk thanks to diversification.

Motley Fool contributor Tristan Harrison has positions in Brickworks, Centuria Industrial REIT, Fortescue, Rural Funds Group, SiteMinder, and VanEck Msci International Quality ETF. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended BetaShares Nasdaq 100 ETF, Brickworks, Lovisa, Pinnacle Investment Management Group, and SiteMinder. The Motley Fool Australia has positions in and has recommended BetaShares Nasdaq 100 ETF, Brickworks, Pinnacle Investment Management Group, Rural Funds Group, and SiteMinder. The Motley Fool Australia has recommended BHP Group, Gqg Partners, Lovisa, and VanEck Morningstar Wide Moat ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

a hand reaches out with australian banknotes of various denominations fanned out.
Dividend Investing

These 2 ASX dividend shares are great buys right now

These defensive names look like strong picks today.

Read more »

Four piles of coins, each getting higher, with trees on them.
Growth Shares

2 ASX 200 shares that could be top buys for growth

These two businesses have an exciting future.

Read more »

Two IT professionals walk along a wall of mainframes in a data centre discussing various things
Technology Shares

This ASX 200 share is being labelled one of the market's most undervalued by brokers

NextDC shares have pulled back sharply, but brokers believe the long-term growth story remains firmly on track.

Read more »

Hand holding out coal in front of a coal mine.
Energy Shares

Up 25% in 2025: Is Whitehaven Coal still a buy?

After a strong 25% run this year, investors are asking whether Whitehaven Coal still has more upside left.

Read more »

Five guys in suits wearing brightly coloured masks, they are corporate superheroes.
Opinions

5 ASX shares I'd buy with $10,000 this week

These are the ASX stocks I have my eye on this week.

Read more »

bull market model with a bull looking at a rising chart
Opinions

By December 2026, $1,000 invested in EOS shares could be worth…

With its share price taking off and contracts piling up, EOS is shaping up as one of the most compelling…

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »